查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1991384

2026-2034年全球外泌体市场规模、份额、趋势和成长分析报告

Global Exosomes Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 169 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计外泌体市场将从 2025 年的 5.9 亿美元成长到 2034 年的 63.8 亿美元，2026 年至 2034 年的复合年增长率为 30.37%。

由于细胞生物学和再生医学研究的进展，全球外泌体市场正经历显着成长。外泌体是细胞释放的微小细胞外囊泡，在细胞间通讯和分子运输中发挥至关重要的作用。科学家正在探索其在诊断、药物传递和治疗方面的潜在应用，尤其是在肿瘤学和再生医学领域。

多种因素正在推动外泌体市场的扩张。生物医学研究投入的增加以及人们对个人化医疗日益增长的兴趣，促使科学家探索外泌体的治疗潜力。由于外泌体能够递送蛋白质和RNA等生物分子，它们正成为疾病检测和标靶治疗的重要工具。

随着研究的深入和临床应用的发展，外泌体市场预计未来将持续成长。分离和表征技术的进步有望促进外泌体在医学研究和治疗方法开发中的应用。随着生物技术和生命科学产业的不断创新，外泌体将成为下一代治疗策略的关键组成部分。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球外泌体市场：依产品与服务划分

  • 市场分析、洞察与预测
  • 试剂盒和试剂
  • 抗体
  • 用于分离、纯化和定量分析的试剂盒和试剂。
  • 其他试剂盒和试剂
  • 装置
  • 服务

第五章 全球外泌体市场：依应用划分

  • 市场分析、洞察与预测
  • 诊断
  • 治疗

第六章：全球外泌体市场：依适应症划分

  • 市场分析、洞察与预测
  • 癌症
  • 神经退化性疾病
  • 心血管疾病
  • 感染疾病
  • 其他迹象

第七章 全球外泌体市场：依最终用户划分

  • 市场分析、洞察与预测
  • 製药和生物技术公司
  • 医院和诊断中心
  • 学术研究机构

第八章 全球外泌体市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第九章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第十章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Thermo Fisher Scientific Inc
    • Bio-Techne Corp
    • QIAGEN
    • Beckam Coulter（Danaher Corp）
    • Diagenode（Hologic Inc）
    • Lonza
    • Abcam
    • RoosterBio Inc
    • Miltenyi Biotech
    • Fujifilm Holdings Corp
    • Hitachi Chemical Diagnostics Inc
    • Clara Biotech
简介目录
Product Code: VMR11213631

The Exosomes Market size is expected to reach USD 6.38 Billion in 2034 from USD 0.59 Billion (2025) growing at a CAGR of 30.37% during 2026-2034.

The global exosomes market has experienced significant growth due to increasing research in cell biology and regenerative medicine. Exosomes are tiny extracellular vesicles released by cells that play an important role in cell communication and molecular transport. Scientists are exploring their potential applications in diagnostics, drug delivery, and therapeutic treatments, particularly in oncology and regenerative medicine.

Several drivers are supporting the expansion of the exosomes market. Growing investment in biomedical research and increasing interest in personalized medicine have encouraged scientists to study the therapeutic potential of exosomes. Their ability to carry biological molecules such as proteins and RNA makes them valuable tools in disease detection and targeted therapies.

Looking ahead, the exosomes market is expected to expand as research advances and clinical applications develop. Improvements in isolation and characterization technologies may enhance the use of exosomes in medical research and treatment development. As biotechnology and life sciences industries continue to innovate, exosomes are likely to become an important component of next-generation therapeutic strategies.

MARKET SEGMENTATION

By Products & Services

  • Kits & Reagents
  • Antibodies
  • Isolation, Purification, Quantitation Kits & Reagents
  • Other Kits & Reagents
  • Instruments
  • Services

By Application

  • Diagnostic
  • Therapeutic

By Indication

  • Cancer
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Other Indications

By End-Users

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc, BioTechne Corp, QIAGEN, Beckam Coulter Danaher Corp, Diagenode Hologic Inc, Lonza, Abcam, RoosterBio Inc, Miltenyi Biotech, Fujifilm Holdings Corp, Hitachi Chemical Diagnostics Inc, Clara Biotech
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXOSOMES MARKET: BY PRODUCTS & SERVICES 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Products & Services
  • 4.2. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Isolation, Purification, Quantitation Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Other Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EXOSOMES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Diagnostic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Therapeutic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EXOSOMES MARKET: BY INDICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Indication
  • 6.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Neurodegenerative Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EXOSOMES MARKET: BY END-USERS 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-users
  • 7.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Hospitals & Diagnostics Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EXOSOMES MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Products & Services
    • 8.2.2 By Application
    • 8.2.3 By Indication
    • 8.2.4 By End-users
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Products & Services
    • 8.3.2 By Application
    • 8.3.3 By Indication
    • 8.3.4 By End-users
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Products & Services
    • 8.4.2 By Application
    • 8.4.3 By Indication
    • 8.4.4 By End-users
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Products & Services
    • 8.5.2 By Application
    • 8.5.3 By Indication
    • 8.5.4 By End-users
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Products & Services
    • 8.6.2 By Application
    • 8.6.3 By Indication
    • 8.6.4 By End-users
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EXOSOMES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Thermo Fisher Scientific Inc
    • 10.2.2 Bio-Techne Corp
    • 10.2.3 QIAGEN
    • 10.2.4 Beckam Coulter (Danaher Corp)
    • 10.2.5 Diagenode (Hologic Inc)
    • 10.2.6 Lonza
    • 10.2.7 Abcam
    • 10.2.8 RoosterBio Inc
    • 10.2.9 Miltenyi Biotech
    • 10.2.10 Fujifilm Holdings Corp
    • 10.2.11 Hitachi Chemical Diagnostics Inc
    • 10.2.12 Clara Biotech